Skip to main content
Top

Noninvasive screening for surgery in adults with simple shunting congenital heart disease

Published in:

Abstract

Objectives

The aim of this study was to use non-invasive parameters to assess eligibility to undergo surgery in patients with adult congenital heart disease (CHD).

Methods

This is a single-center retrospective study that collected patients’ demographic data, right heart catheterization, complete blood count, N-terminal pro-brain natriuretic peptide (NT-proBNP), arterial blood gas, pulmonary function test (PFT), cardiopulmonary exercise testing (CPET), and echocardiographic parameters. Surgical eligibility of patients was evaluated based on hemodynamic parameters, specifically pulmonary vascular resistance (PVR) < 4.6 WU and pulmonary vascular resistance index (PVRI) < 8 WU ▪ m2. Univariate analysis was employed to compare baseline parameters between the two patient groups. Independent predictive factors were determined using binary logistic regression analysis.

Results

A total of 81 patients with adult CHD were included in the study, with 34 qualifying for surgery and 47 not meeting the criteria for surgery. The group eligible for surgery exhibited superior hemodynamics, higher oxygen partial pressure, and better diffusion capacity compared to the non-eligible group. Echocardiographic findings revealed lower systolic pulmonary artery pressure (SPAP) in the eligible group (79.23 ± 23.56 vs. 98.91 ± 20.23 mmHg, p = 0.00), higher tricuspid annular plane systolic excursion (TAPSE) (2.10 (1.88, 2.50) vs. 1.81 (1.70, 2.01) cm, p = 0.001), and increased TAPSE/SPAP ratio (0.32 ± 0.14 vs. 0.20 ± 0.59 mm/mmHg, p = 0.00). TAPSE/SPAP emerged as an independent predictor, with an area under the receiver operating characteristic (ROC) curve of 0.81 (95% CI: 0.70–0.92, p < 0.01).

Conclusions

The echocardiographic parameter TAPSE/SPAP may be a valuable index to evaluate whether patients with coronary artery disease are suitable for surgery.
Title
Noninvasive screening for surgery in adults with simple shunting congenital heart disease
Authors
Xingxing Sun
Yang Chen
Jianhua Xu
Hongyu Gao
Hanqing Zhu
Bigyan Pudasaini
Wenlan Yang
Yuan Cao
Jian Guo
Publication date
07-01-2026
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME